The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.
Download Report Overview
SCOPE AND FORMAT
The study scope includes Sanger, next-generation and emerging sequencing technologies. The markets for sample preparation products, sequencing instruments and consumables, bioinformatics and sequencing services are given for 2010 and 2011, and also forecast through 2016.
BCC examines the sequencing industry structure for the key market segments, as well as strategic alliances and acquisitions and sequencing patents. The strategies of the main sequencing companies are discussed. The main sequencing services markets are described, including diagnostics, consumer, research and development (R&D) and applied.
BCC provides information for global markets, including North America, Europe and Asia-Pacific. Specific country forecasts include the U.S., the U.K., Germany, China and Japan.
John Bergin has written previous BCC Research biotechnology reports titled Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-Chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; Synthetic Biology: Emerging Global Markets; and Biologic Imaging Reagents: Technologies and Global Markets. Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company and has held executive management positions with a nanotechnology company. Mr. Bergin holds a B.S. Chemistry, a M.S. Biotechnology and a Masters of Business Administration.